{"disease":{"id":"ebv-viremia","name":"ebv viremia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06681025","title":"Clinical Performance Evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Immunocompromised Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1070,"lead_sponsor_name":"QIAGEN Gaithersburg, Inc","has_results":false},{"nct_id":"NCT04189835","title":"EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":509,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07438067","title":"EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"Daihong Liu","has_results":false},{"nct_id":"NCT02822495","title":"Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Atara Biotherapeutics","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}